Ebit Endring Dato
AbbVie USD 4.52B 378M 2023-09
Adma Biologics USD 14.23M 5.55M 2023-12
Amgen USD 1.8B 254M 2023-12
AstraZeneca USD 2.15B 418M 2023-09
Dynavax Technologies USD -7005000 12.01M 2023-12
Gilead Sciences USD 2.15B 475M 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -125000000 2.34B 2023-12
Regeneron Pharmaceuticals USD 1B 208.1M 2023-12
Roche Holding CHF 10.6B 2.12B 2023-06
Sarepta Therapeutics USD -20842000 112.68M 2023-09
TG Therapeutics USD -12485000 127.27M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Dynavax Technologies - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.